Resources from the same session
Molecular profiling, prognosis and present Guidelines for Relapsed/Refractory AML
Presenter: Lars Bullinger
Session: ESMO Colloquium supported by Daiichi Sankyo Europe GmbH - Relapsed/Refractory FLT3-ITD mutated Acute Myeloid Leukemias (AML)
Resources:
Slides
Webcast
Recent results with FLT3 Inhibitors in FLT3-ITD positive Relapsed/Refractory AML and future development
Presenter: Jorge Cortes
Session: ESMO Colloquium supported by Daiichi Sankyo Europe GmbH - Relapsed/Refractory FLT3-ITD mutated Acute Myeloid Leukemias (AML)
Resources:
Slides
Webcast